Somatic mutations altering Tyr641 of EZH2 are rare in primary central nervous system lymphoma
- PMID: 20858097
- DOI: 10.3109/10428194.2010.510897
Somatic mutations altering Tyr641 of EZH2 are rare in primary central nervous system lymphoma
Similar articles
-
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.Nat Genet. 2010 Feb;42(2):181-5. doi: 10.1038/ng.518. Epub 2010 Jan 17. Nat Genet. 2010. PMID: 20081860 Free PMC article.
-
Absence of mutations of the histone methyltransferase gene EZH2 in splenic b-cell marginal zone lymphoma.Leuk Res. 2011 Mar;35(3):e23-4. doi: 10.1016/j.leukres.2010.10.014. Epub 2010 Nov 18. Leuk Res. 2011. PMID: 21087793 No abstract available.
-
Mutational analysis of EZH2 codon 641 in non-Hodgkin lymphomas and leukemias.Leuk Res. 2011 Jan;35(1):e6-7. doi: 10.1016/j.leukres.2010.08.018. Epub 2010 Sep 21. Leuk Res. 2011. PMID: 20863566 No abstract available.
-
[Recent advances on EZH2 in malignant tumors].Zhonghua Bing Li Xue Za Zhi. 2009 Dec;38(12):856-8. Zhonghua Bing Li Xue Za Zhi. 2009. PMID: 20193471 Review. Chinese. No abstract available.
-
Functional roles of enhancer of zeste homolog 2 in gliomas.Gene. 2016 Jan 15;576(1 Pt 2):189-94. doi: 10.1016/j.gene.2015.09.080. Epub 2015 Oct 20. Gene. 2016. PMID: 26435191 Review.
Cited by
-
Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t(14;18)-positive follicular lymphoma.Leukemia. 2014 May;28(5):1103-12. doi: 10.1038/leu.2013.307. Epub 2013 Oct 23. Leukemia. 2014. PMID: 24153014
-
Integrated miRNA and mRNA expression profiling in fetal hippocampus with Down syndrome.J Biomed Sci. 2016 Jun 7;23(1):48. doi: 10.1186/s12929-016-0265-0. J Biomed Sci. 2016. PMID: 27266699 Free PMC article.
-
Molecular Update and Evolving Classification of Large B-Cell Lymphoma.Cancers (Basel). 2021 Jul 3;13(13):3352. doi: 10.3390/cancers13133352. Cancers (Basel). 2021. PMID: 34283060 Free PMC article. Review.
-
TET2 suppresses nasopharyngeal carcinoma progression by inhibiting glycolysis metabolism.Cancer Cell Int. 2020 Aug 3;20:363. doi: 10.1186/s12935-020-01456-9. eCollection 2020. Cancer Cell Int. 2020. PMID: 32774157 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical